VERV - Verve Therapeutics Inc
IEX Last Trade
6.71
0.580 8.644%
Share volume: 2,854,469
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$6.13
0.58
9.46%
Summary score
13%
Profitability
8%
Dept financing
6%
Liquidity
75%
Performance
5%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-9.64%
Return on assets
-8.7%
Return on sales
-2872.86%
Return on invested capital
1925.39%
Total debt ratio
17.5%
Debt ratio change over timeo
-1.25%
Current Ratio
16.71%
Quick Ratio
16.71%
Cash Position Ratio
16.38%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-9.49%
Return on assets
-8.35%
Return on sales
-1631.22%
Return on invested capital
-61.27%
Total debt ratio
21.65%
Debt ratio change over timeo
-1.28%
Current Ratio
16.45%
Quick Ratio
16.45%
Cash Position Ratio
16.07%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-8.36%
Return on assets
-7.76%
Return on sales
-998.14%
Return on invested capital
-60.36%
Total debt ratio
20.38%
Debt ratio change over time
-1.33%
Current Ratio
19.82%
Quick Ratio
19.82%
Cash Position Ratio
19.38%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-87.18%
Return on assets
-88.55%
Return on sales
4185.85%
Return on invested capital
-3751.21%
Total debt ratio
-125.16%
Debt ratio change over time
-1.25%
Current Ratio
-22.85%
Quick Ratio
-22.85%
Cash Position Ratio
-22.42%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | VERV | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -9.64% | 13.79% | 34.47% | 7.43% |
| Return on assets | -8.7% | 2.76% | 3.15% | 5.62% |
| Return on sales | -2872.86% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 1925.39% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 40% | 59% | 56% |
| Total debt ratio | 17.5% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.25% | 308.97% | -6.99% | 1.18% |
| Dept financing | 5% | 50% | 25% | 7% |
| Current Ratio | 16.45% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 16.45% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 16.07% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 3% | 7% | 15% |
| Short-term ratios | VERV | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -9.49% | 13.77% | 13.25% | 3.8% |
| Return on assets | -8.35% | 2.43% | 1.89% | 3.09% |
| Return on sales | -1631.22% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -61.27% | 2.14% | 3.39% | 9.18% |
| Profitability | 0% | 71% | 68% | 82% |
| Total debt ratio | 21.65% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -1.28% | 46.38% | -72.08% | 1.51% |
| Dept financing | 6% | 50% | 25% | 7% |
| Current Ratio | 16.45% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 16.45% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 16.07% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 3% | 8% | 20% |